BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19736553)

  • 1. Imaging myocardial angiogenesis.
    Wykrzykowska JJ; Henry TD; Lesser JR; Schwartz RS
    Nat Rev Cardiol; 2009 Oct; 6(10):648-58. PubMed ID: 19736553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia.
    Sabe AA; Potz BA; Elmadhun NY; Liu Y; Feng J; Abid MR; Abbott JD; Senger DR; Sellke FW
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):245-52. PubMed ID: 26478238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factor-induced therapeutic angiogenesis in the heart: protein therapy.
    Annex BH; Simons M
    Cardiovasc Res; 2005 Feb; 65(3):649-55. PubMed ID: 15664391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of coronary vasculature in ischemic hearts by plant-derived angiogenic compounds.
    Chen H; Peng P; Cheng L; Lin X; Chung SS; Li M
    Int J Cardiol; 2012 Apr; 156(2):148-55. PubMed ID: 21130507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent insights into human coronary collateral development.
    Fujita M; Tambara K
    Heart; 2004 Mar; 90(3):246-50. PubMed ID: 14966033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines.
    Losordo DW; Dimmeler S
    Circulation; 2004 Jun; 109(21):2487-91. PubMed ID: 15173038
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic angiogenesis for myocardial ischemia.
    Rosinberg A; Khan TA; Sellke FW; Laham RJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):271-83. PubMed ID: 15151475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel molecular targets for coronary angiogenesis and ischemic heart disease.
    Potz BA; Parulkar AB; Abid RM; Sodha NR; Sellke FW
    Coron Artery Dis; 2017 Nov; 28(7):605-613. PubMed ID: 28678145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of VEGF delivery techniques on collateral-dependent microvascular reactivity.
    Sellke FW; Tofukuji M; Laham RJ; Li J; Hariawala MD; Bunting S; Simons M
    Microvasc Res; 1998 Mar; 55(2):175-8. PubMed ID: 9521892
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of aging on the angiogenic potential of the myocardium: implications for angiogenic therapies with emphasis on sirtuin agonists.
    Wykrzykowska JJ; Bianchi C; Sellke FW
    Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):119-32. PubMed ID: 19519554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs.
    Lu H; Xu X; Zhang M; Cao R; Bråkenhielm E; Li C; Lin H; Yao G; Sun H; Qi L; Tang M; Dai H; Zhang Y; Su R; Bi Y; Zhang Y; Cao Y
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12140-5. PubMed ID: 17636133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Therapeutic angiogenesis.
    Kastrup J; Jørgensen E; Drvota V
    Scand Cardiovasc J; 2001 Oct; 35(5):291-6. PubMed ID: 11771818
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic angiogenesis for ischemic heart disease.
    Kawasuji M
    Ann Thorac Cardiovasc Surg; 2002 Apr; 8(2):59-61. PubMed ID: 12035771
    [No Abstract]   [Full Text] [Related]  

  • 14. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits.
    Hershey JC; Baskin EP; Corcoran HA; Bett A; Dougherty NM; Gilberto DB; Mao X; Thomas KA; Cook JJ
    Heart Vessels; 2003 Jul; 18(3):142-9. PubMed ID: 12955430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II angiogenesis stimulators.
    Ribatti D; Baiguera S
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1157-66. PubMed ID: 23790062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stimulated angiogenesis: a new trend in the treatment of ischemic conditions].
    Davydenko VV; Machs VM
    Vestn Khir Im I I Grek; 2000; 159(1):117-20. PubMed ID: 10890120
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia.
    Sato K; Laham RJ; Pearlman JD; Novicki D; Sellke FW; Simons M; Post MJ
    Ann Thorac Surg; 2000 Dec; 70(6):2113-8. PubMed ID: 11156130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome.
    Robich MP; Chu LM; Chaudray M; Nezafat R; Han Y; Clements RT; Laham RJ; Manning WJ; Coady MA; Sellke FW
    Surgery; 2010 Aug; 148(2):453-62. PubMed ID: 20570307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen therapy induces collateral and microvascular remodeling.
    Lamping KG; Christensen LP; Tomanek RJ
    Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2039-44. PubMed ID: 12855426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.